PLAU and arthritic joint disease: While tissue-type plasminogen activator (t-PA)-/- mice display more severe arthritis in both monoarticular and polyarticular models, attributable to increased fibrin deposition in the joint [3,7], in models incorporating an i.a. injection, u-PA may also play a role in such fibrinolysis [2,6].